Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Microbial protein cell factories fight back?

16 Dec 2021

Abstract excerpt

The biopharmaceutical market is growing faster than ever, with two production systems competing for market dominance: mammalian cells and microorganisms. In recent years, based on the rise of antibody-based therapies, new biotherapeutic approvals have favored mammalian hosts. However, not only has extensive research elevated our understanding of microbes to new levels, but emerging therapeutic molecules also...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Monoclonal and Polyclonal Antibodies Research
Share to Transgenic Plants and Applications
Share to Viral Infectious Diseases and Gene Expression in Insects

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34924209
DOI: 10.1016/j.tibtech.2021.10.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Microbial protein cell factories fight back?PMID 34924209Read ↗

Reexamining opportunities for therapeutic protein production in eukaryotic microorganismsSemantic proximity Read ↗

Understanding K. phaffii ( Pichia pastoris ) Host Cell Proteins: Proteomic Analysis and Flow-through Affinity ClearanceSemantic proximity Read ↗

Host cell proteins in biologics development: Identification, quantitation and risk assessmentSemantic proximity Read ↗

Expression of antibody fragments in Saccharomyces cerevisiae strains evolved for enhanced protein secretionSemantic proximity Read ↗

Detection of host cell microprotein impurities in antibody drug productsSemantic proximity Read ↗

Recent advances in (therapeutic protein) drug developmentSemantic proximity Read ↗

Adaptation of Aglycosylated Monoclonal Antibodies for Improved Production in Komagataella phaffiiSemantic proximity Read ↗

Adaptation of Aglycosylated Monoclonal Antibodies for Improved Production in Komagataella phaffiiSemantic proximity Read ↗

Proteomic differences in recombinant CHO cells producing two similar antibody fragmentsSemantic proximity Read ↗

Development of therapeutic proteins: advances and challengesSemantic proximity Read ↗

Production systems for recombinant antibodiesSemantic proximity Read ↗

Advances in recombinant antibody manufacturingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.